GSK3B and breast cancer: In support of this, complete inhibition of GSK3β with MeBIO caused a significant increase in GLI1 expression, whereas the introduction of constitutively active GSK3β by the transfection of breast cancer cells enhanced drug retention ability that is abrogated by OPN treatment.